Therefore, the effects of ADAM9 KD on EGFR activation observed previously are likely specific to the esophageal squamous cell carcinoma cells examined, and there are alternative mechanisms through which ADAM9 regulates Akt in other cells and tissues. Here, ADAM9 is linked to esophageal squamous cell carcinoma.